MedTrace Logo

A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys

NCT00520832 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-10-17

No results posted yet for this study

Summary

Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia.

The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.

Conditions

  • Primary Insomnia

Interventions

DEVICE

Microcurrent

20 minutes of sub-threshold microcurrent 2 hours before bedtime per day for 21 days.

DEVICE

Microcurrent

Participants will receive a device identical to the active device used in the experimental condition, but which produces no current.

Sponsors & Collaborators

  • Logan College of Chiropractic

    lead OTHER

Principal Investigators

  • Rodger Tepe, PhD · Logan College of Chiropractic

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00520832 on ClinicalTrials.gov